Ph.D Research

Swami Rama Himalayan University (SRHU) is a research-driven institution committed to advancing knowledge through innovation, interdisciplinary collaboration, and translational impact. Nestled in the Himalayan foothills, SRHU is a unique treasure trove of biodiversity and conserved gene pools—providing exceptional opportunities for scientific exploration, health research, technology development, and societal transformation. With state-of-the-art laboratories, an NABL-accredited diagnostic ecosystem, a 1,200+ bed teaching hospital, access to a comprehensive Learning Management System (LMS), and strong cross-disciplinary expertise, SRHU offers an outstanding environment for high-quality doctoral research. Its strategic location draws students from rural Himalayan regions to metropolitan India, contributing significantly to multi-dimensional capacity building. SRHU is recognized as a Scientific and Industrial Research Organization (SIRO) by the Department of Scientific and Industrial Research (DSIR), Government of India. The University also hosts an Intellectual Property Management Cell (IPMC), initially sanctioned by the UCOST and now maintained by university, enabling researchers to protect and commercialize intellectual property and fostering a culture of creativity and innovation..

Interdisciplinary Research Ecosystem

SRHU brings together diverse discipline i.e Medicine & Health Sciences, Biosciences, Nursing, Pharmacy, Management, Engineering & Technology, Yoga Sciences, Psychology, Clinical Research, and Computer Science to create a seamless research environment leading
from:

    • Science to Medicine
    • Bench to Bedside Translation
    • Technology to Production
    • Management to Business Strategy

This synergy enables researchers to test, validate, and refine ideas using the University’s robust clinical, laboratory, and computational infrastructure.
Research begins early at SRHU. UG and PG students engage in course-embedded research projects and later undertake independent studies with faculty and industry mentors—building a strong pipeline of future scientists and innovators.

Research Support & Funding

SRHU provides in-house seed research grants to encourage faculty-led and student-led innovation. A dedicated Internal Research Committee evaluates and supports impactful projects, especially those targeting translational outcomes. Departments also secure substantial extramural funding from bodies such as ICMR, UCOST, CSIR, DBT, ANRF and other national agencies.

Research Capacity Building

To strengthen research culture, the University regularly conducts:
• National seminars & international symposia
• Hands-on training workshops
• Research methodology & data analysis programs
• Specialized training in Bio-IT tools and AI applications in healthcare

SRHU hosted the Indo–UK Symposium on “Precision Medicine: Genes, Environment the Data Challenge”—reflecting the University’s global engagement and scientific leadership.
The University has also launched a flagship M.Sc. in Clinical Research, cultivating cross-disciplinary skills in data science, clinical investigations, and translational medicine. Students are already contributing to research on cancer pain burden, neurodevelopment, iodine deficiency disorders, thyroid profiling, and maternal–fetal outcomes.

Ph.D. Programmes Offered at SRHU

SRHU fosters a dynamic research environment across Medical Sciences, Biosciences, Technology, and Allied disciplines. Key research thrusts include:
Biochemistry, Biotechnology & Microbiology
Environmental biotechnology, molecular & cell biology, genetics, nano-toxicology, virology, bioinformatics & systems biology.

Epidemiology & Public Health

Cancer and cardiovascular epidemiology, infectious diseases, environmental & occupational health, molecular epidemiology, public/population health.

Immunology

Cancer immunology, autoimmunity, immune development, infectious disease immunology, transplantation immunology.

Cancer Biology / Cancer Medicine

Cancer genomics, immunotherapy, vaccines, metabolism, clinical oncology, drug development, clinical trials, community oncology, palliative care.

Pharmacy

Pharmaceutics, pharmaceutical chemistry, clinical pharmacology, pharmacovigilance, pharmaco-economics.

Pharmacology (Medical)

Clinical pharmacology, Cardiovascular pharmacology, Neuropharmacology, Respiratory pharmacology, Renal pharmacology, Gastrointestinal pharmacology, Cancer pharmacology, Pharmacovigilance, Adverse drug reaction monitoring, Drug interaction studies, Pharmaco-epidemiological studies and Pharmaco-economics, Drug utilization studies.

Nursing Sciences

Community health, child health, mental health, medical-surgical, obstetrics & gynecological nursing.

Psychology

Cognitive and behavioural sciences, personality research, neurocognitive models, behaviour modification, yoga-based interventions.

Yoga Sciences

Yogic philosophy, Hatha Yoga, mind–body medicine, wellness research, lifestyle interventions.

Physiology

Exercise physiology, stress & lifestyle disorders, occupational health, yoga physiology.

Clinical Research

Drug discovery, regulatory science, precision medicine, AI-driven analytics, health technology assessment.

Computer Science

Artificial intelligence, machine learning, data science, cyber security, IoT, cloud computing, blockchain, wireless networks, software engineering.

University offers PhD program in the following areas:

S. No. Specializations Code Eligible Subjects Eligibility to seek admission in Ph.D. program as per the UGC (Minimum Standards and Procedures for Award of Ph.D. Degree) Regulations, 2022
1 Biochemistry 01 Master’s degree in Biochemistry/ Biotechnology or any other related fields

Eligibility to seek admission to the Ph.D. program will be:

  1. Candidates who have completed any of the following:
    • 1-year/2-semester master’s degree programme after a 4-year/8-semester bachelor’s degree program OR
    • 2-year/4-semester master’s degree programme after a 3-year bachelor’s degree program OR
    • Qualifications declared equivalent to the master’s degree by the corresponding statutory regulatory body OR
    • Provided that a candidate seeking admission after a 4-year/8-semester bachelor’s degree program has a minimum of 75% marks in aggregate or its equivalent grade on a point scale wherever the grading system is followed.
  2. Candidates who have completed the M.Phil. program with at least 55% marks in aggregate or its equivalent grade in a point scale wherever grading system is followed, or equivalent qualification from a foreign educational institution accredited by an authorized body.
  3. Candidates must have secured at least 55% marks in aggregate or its equivalent grade in a point scale wherever grading system is followed, or equivalent qualification from an accredited foreign educational institution.
  4. A relaxation of 5% marks or its equivalent grade may be allowed for those belonging to SC/ST/OBC (non-creamy layer)/Differently Abled/Economically Weaker Section (EWS) and other categories as per UGC norms.
2Biotechnology02Master’s degree in Biotechnology/ Biochemistry/ Botany/ Zoology/ Microbiology or any other related fields
3Epidemiology04Master’s degree in Epidemiology/ Community Medicine or M.Sc. in Clinical Research
4Immunology06Master’s degree in Immunology/ Biochemistry/ Biotechnology/ Microbiology or any other related fields
5Management (Finance, Human Resource, Marketing)07Master’s degree in Commerce/ Business Administration/ Human Resource Management/ Finance/ Marketing or any other related fields
6Medical Physics08Master’s degree in Medical Physics or Master’s degree in Physics with Post M.Sc. Diploma in Medical Physics
7Microbiology09Master’s degree in Microbiology/ Biotechnology or any other related fields
8Nursing Sciences10Master’s degree in Nursing Sciences or any other related fields
9Cancer Biology/ Cancer Medicine11Master’s degree in Oncology Sciences/ Pharmacology/ Microbiology/ Biochemistry/ Biotechnology or any other related fields
10Pharmacology (Medical)12Master’s degree in Pharmacology or any other related fields
11Pharmacy (Pharmaceutics, Pharmaceutical Chemistry, Pharmacology)13M. Pharm in appropriate branch of specialization in Pharmacy or related fields
12Psychology14Master’s degree in Psychology/ Neuropsychology/ Child Psychology/ Cognitive Psychology/ Rehabilitation Psychology/ Applied Psychology/ Social Psychology (in regular mode)
13Physiology15Master’s degree in Physiology or any other related fields
14Yoga Sciences16Master’s degree in Yoga or any other related fields
15Clinical Research17Master’s Degree (Bio-based) or a professional degree (Bio-based) declared equivalent to master’s degree by the corresponding statutory body
16Medical Biochemistry18MD Biochemistry / P.G Diploma in Clinical Pathology / Postgraduate degree in Medical Biochemistry (M.Sc) via regular mode
17Computer Science19Master’s degree in Computer Science/ Computer Applications/ Information Technology (e.g., M.Sc. Computer Science, M.C.A., M.Tech./M.E. in CS/IT or equivalent)
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.